{"entity":{"type":"insider","cik":"0001583977","url":"/insider/0001583977","json_url":"/insider/0001583977.json","name":"Cormorant Asset Management, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":157,"n_filings":63,"first":"2016-11-07","last":"2026-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Cormorant Asset Management, LP","source":"filing","n_filings":54,"first_seen":"2018-05-31","last_seen":"2026-08-10"},{"name":"Cormorant Asset Management, LLC","source":"filing","n_filings":9,"first_seen":"2016-11-07","last_seen":"2017-12-18"}],"transactions":[{"id":9276040,"accession":"0001231919-26-000852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000852","line_url":"/filing/0001231919-26-000852#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"BlossomHill Therapeutics, Inc.","issuer_ticker":"BLSM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund V LP; Cormorant Private Healthcare Fund VI, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":3614034.0,"shares_owned_after_display":"3,614,034","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-10","scope":"insider"},{"id":5738820,"accession":"0000929638-26-001708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-26-001708","line_url":"/filing/0000929638-26-001708#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"BRIGHT MINDS BIOSCIENCES INC.","issuer_ticker":"DRUG","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":109331.0,"shares_display":"109,331","price_per_share":89.5,"price_display":"89.50","price_state":"stated","total_value":9785124.5,"total_display":"9,785,124.50","total_whole":"9,785,125","shares_owned_after":950000.0,"shares_owned_after_display":"950,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-04-28","filed_date":"2026-04-30","scope":"insider"},{"id":4523741,"accession":"0000929638-25-004597","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-25-004597","line_url":"/filing/0000929638-25-004597#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30029.0,"shares_display":"30,029","price_per_share":11.456,"price_display":"11.46","price_state":"stated","total_value":344012.224,"total_display":"344,012.22","total_whole":"344,012","shares_owned_after":2344971.0,"shares_owned_after_display":"2,344,971","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-11","filed_date":"2025-12-15","scope":"insider"},{"id":4698787,"accession":"0000929638-25-004521","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-25-004521","line_url":"/filing/0000929638-25-004521#line-1","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":15.704,"price_display":"15.70","price_state":"stated","total_value":942240.0,"total_display":"942,240.00","total_whole":"942,240","shares_owned_after":8265000.0,"shares_owned_after_display":"8,265,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-08","scope":"insider"},{"id":4192953,"accession":"0000929638-25-003712","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000929638-25-003712","line_url":"/filing/0000929638-25-003712#line-5","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5827.0,"shares_display":"5,827","price_per_share":6.96,"price_display":"6.96","price_state":"stated","total_value":40555.92,"total_display":"40,555.92","total_whole":"40,556","shares_owned_after":1994173.0,"shares_owned_after_display":"1,994,173","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-01","scope":"insider"},{"id":4192948,"accession":"0000929638-25-003712","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000929638-25-003712","line_url":"/filing/0000929638-25-003712","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"MoonLake Immunotherapeutics","issuer_ticker":"MLTX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund II, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6494151.0,"shares_display":"6,494,151","price_per_share":7.210739045026825,"price_display":"7.21","price_state":"stated","total_value":46827628.18,"total_display":"46,827,628.18","total_whole":"46,827,628","shares_owned_after":4800000.0,"shares_owned_after_display":"4,800,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-10-01","scope":"insider","n_lines":4},{"id":5149439,"accession":"0000929638-25-001950","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-25-001950","line_url":"/filing/0000929638-25-001950#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP; Cormorant Private Healthcare Fund V LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1813439.0,"shares_display":"1,813,439","price_per_share":1.8545,"price_display":"1.85","price_state":"stated","total_value":3363022.6255,"total_display":"3,363,022.63","total_whole":"3,363,023","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-19","scope":"insider"},{"id":4574246,"accession":"0000929638-25-001870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-25-001870","line_url":"/filing/0000929638-25-001870#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP; Cormorant Private Healthcare Fund V LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24300.0,"shares_display":"24,300","price_per_share":1.985,"price_display":"1.98","price_state":"stated","total_value":48235.5,"total_display":"48,235.50","total_whole":"48,236","shares_owned_after":1813439.0,"shares_owned_after_display":"1,813,439","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-12","filed_date":"2025-05-14","scope":"insider"},{"id":5105596,"accession":"0000929638-25-000822","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-25-000822","line_url":"/filing/0000929638-25-000822#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Aardvark Therapeutics, Inc.","issuer_ticker":"AARD","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":987689.0,"shares_owned_after_display":"987,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-19","scope":"insider"},{"id":2233906,"accession":"0000929638-24-003752","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-24-003752","line_url":"/filing/0000929638-24-003752#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"BRIGHT MINDS BIOSCIENCES INC.","issuer_ticker":"DRUG","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":184331.0,"shares_display":"184,331","price_per_share":21.7,"price_display":"21.70","price_state":"stated","total_value":3999982.7,"total_display":"3,999,982.70","total_whole":"3,999,983","shares_owned_after":1059331.0,"shares_owned_after_display":"1,059,331","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-04","filed_date":"2024-11-06","scope":"insider"},{"id":3150336,"accession":"0000929638-24-003542","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000929638-24-003542","line_url":"/filing/0000929638-24-003542","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"BRIGHT MINDS BIOSCIENCES INC.","issuer_ticker":"DRUG","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":23.45625998,"price_display":"23.46","price_state":"stated","total_value":1172812.999,"total_display":"1,172,813.00","total_whole":"1,172,813","shares_owned_after":864743.0,"shares_owned_after_display":"864,743","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-16","filed_date":"2024-10-17","scope":"insider","n_lines":3},{"id":3150329,"accession":"0000929638-24-003542","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000929638-24-003542","line_url":"/filing/0000929638-24-003542","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"BRIGHT MINDS BIOSCIENCES INC.","issuer_ticker":"DRUG","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":372591.0,"shares_display":"372,591","price_per_share":5.5330746869892184,"price_display":"5.53","price_state":"stated","total_value":2061573.8307,"total_display":"2,061,573.83","total_whole":"2,061,574","shares_owned_after":690506.0,"shares_owned_after_display":"690,506","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-17","scope":"insider","n_lines":8},{"id":2079689,"accession":"0000929638-24-003363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-24-003363","line_url":"/filing/0000929638-24-003363#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"BioAge Labs, Inc.","issuer_ticker":"BIOA","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Private Healthcare Fund IV LP; Cormorant Private Healthcare Fund V LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":8100000.0,"total_display":"8,100,000.00","total_whole":"8,100,000","shares_owned_after":1629529.0,"shares_owned_after_display":"1,629,529","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-10-01","scope":"insider"},{"id":2059339,"accession":"0000929638-24-003217","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000929638-24-003217","line_url":"/filing/0000929638-24-003217","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":20.010744597142857,"price_display":"20.01","price_state":"stated","total_value":7003760.609,"total_display":"7,003,760.61","total_whole":"7,003,761","shares_owned_after":2301667.0,"shares_owned_after_display":"2,301,667","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-24","scope":"insider","n_lines":6},{"id":2765742,"accession":"0000929638-24-001743","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-24-001743","line_url":"/filing/0000929638-24-001743","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":850000.0,"shares_display":"850,000","price_per_share":11.860848211764706,"price_display":"11.86","price_state":"stated","total_value":10081720.98,"total_display":"10,081,720.98","total_whole":"10,081,721","shares_owned_after":8117847.0,"shares_owned_after_display":"8,117,847","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-05-08","scope":"insider","n_lines":2},{"id":2457024,"accession":"0000929638-24-001536","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-24-001536","line_url":"/filing/0000929638-24-001536","is_derivative":false,"issuer_cik":"0001314102","issuer_name":"EyePoint Pharmaceuticals, Inc.","issuer_ticker":"EYPT","issuer_name_source":null,"issuer_url":"/issuer/0001314102","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":581765.0,"shares_display":"581,765","price_per_share":18.03038371163614,"price_display":"18.03","price_state":"stated","total_value":10489446.18,"total_display":"10,489,446.18","total_whole":"10,489,446","shares_owned_after":7288479.0,"shares_owned_after_display":"7,288,479","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-04-18","filed_date":"2024-04-22","scope":"insider","n_lines":2},{"id":2107561,"accession":"0000929638-24-001336","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000929638-24-001336","line_url":"/filing/0000929638-24-001336","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":2.9004525,"price_display":"2.90","price_state":"stated","total_value":1160181.0,"total_display":"1,160,181.00","total_whole":"1,160,181","shares_owned_after":2895273.0,"shares_owned_after_display":"2,895,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider","n_lines":8},{"id":2818091,"accession":"0000929638-24-001046","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000929638-24-001046","line_url":"/filing/0000929638-24-001046#line-5","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":2.141,"price_display":"2.14","price_state":"stated","total_value":856400.0,"total_display":"856,400.00","total_whole":"856,400","shares_owned_after":3295273.0,"shares_owned_after_display":"3,295,273","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-15","filed_date":"2024-03-18","scope":"insider"},{"id":2818086,"accession":"0000929638-24-001046","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000929638-24-001046","line_url":"/filing/0000929638-24-001046","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Immuneering Corp","issuer_ticker":"IMRX","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":509091.0,"shares_display":"509,091","price_per_share":3.717612941497689,"price_display":"3.72","price_state":"stated","total_value":1892603.29,"total_display":"1,892,603.29","total_whole":"1,892,603","shares_owned_after":3859098.0,"shares_owned_after_display":"3,859,098","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-18","scope":"insider","n_lines":4},{"id":3067321,"accession":"0000929638-24-000985","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000929638-24-000985","line_url":"/filing/0000929638-24-000985#line-10","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":156597.0,"shares_display":"156,597","price_per_share":45.26,"price_display":"45.26","price_state":"stated","total_value":7087580.22,"total_display":"7,087,580.22","total_whole":"7,087,580","shares_owned_after":2016138.0,"shares_owned_after_display":"2,016,138","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-11","scope":"insider"},{"id":3067320,"accession":"0000929638-24-000985","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000929638-24-000985","line_url":"/filing/0000929638-24-000985#line-9","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"Corbus Pharmaceuticals Holdings, Inc.","issuer_ticker":"CRBP","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61668.0,"shares_display":"61,668","price_per_share":44.62,"price_display":"44.62","price_state":"stated","total_value":2751626.16,"total_display":"2,751,626.16","total_whole":"2,751,626","shares_owned_after":1859541.0,"shares_owned_after_display":"1,859,541","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-11","scope":"insider"}],"collapsed":true,"next_cursor":"2024-03-08|3067320","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001839970","name":"BlossomHill Therapeutics, Inc.","url":"/issuer/0001839970","role":"Ten percent owner","n_filings":1,"first_seen":"2026-08-10","last_seen":"2026-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001827401","name":"BRIGHT MINDS BIOSCIENCES INC.","url":"/issuer/0001827401","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2024-10-17","last_seen":"2026-04-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001595097","name":"Corbus Pharmaceuticals Holdings, Inc.","url":"/issuer/0001595097","role":"Ten percent owner","n_filings":5,"first_seen":"2024-01-30","last_seen":"2025-12-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001314102","name":"EyePoint, Inc.","url":"/issuer/0001314102","role":"Ten percent owner, Other","n_filings":6,"first_seen":"2023-12-06","last_seen":"2025-12-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001821586","name":"MoonLake Immunotherapeutics","url":"/issuer/0001821586","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2023-10-04","last_seen":"2025-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001637715","name":"OnKure Therapeutics, Inc.","url":"/issuer/0001637715","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2025-05-14","last_seen":"2025-05-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001774857","name":"Aardvark Therapeutics, Inc.","url":"/issuer/0001774857","role":"Other","n_filings":1,"first_seen":"2025-02-19","last_seen":"2025-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001709941","name":"BioAge Labs, Inc.","url":"/issuer/0001709941","role":"Other","n_filings":1,"first_seen":"2024-10-01","last_seen":"2024-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001790340","name":"Immuneering Corp","url":"/issuer/0001790340","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2021-08-05","last_seen":"2024-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001990550","name":"Ambrx Biopharma, Inc.","url":"/issuer/0001990550","role":"Ten percent owner","n_filings":1,"first_seen":"2023-10-25","last_seen":"2023-10-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001836056","name":"Ambrx Biopharma Inc.","url":"/issuer/0001836056","role":"Ten percent owner","n_filings":4,"first_seen":"2023-03-16","last_seen":"2023-09-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001822691","name":"GreenLight Biosciences Holdings, PBC","url":"/issuer/0001822691","role":"Other","n_filings":1,"first_seen":"2023-07-24","last_seen":"2023-07-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001840439","name":"Biomea Fusion, Inc.","url":"/issuer/0001840439","role":"Ten percent owner","n_filings":2,"first_seen":"2021-04-22","last_seen":"2023-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001761918","name":"Erasca, Inc.","url":"/issuer/0001761918","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2021-07-22","last_seen":"2022-12-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001851194","name":"Ventyx Biosciences, Inc.","url":"/issuer/0001851194","role":"Other","n_filings":1,"first_seen":"2021-10-27","last_seen":"2021-10-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001782223","name":"Pyxis Oncology, Inc.","url":"/issuer/0001782223","role":"Other","n_filings":1,"first_seen":"2021-10-15","last_seen":"2021-10-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001863127","name":"Tyra Biosciences, Inc.","url":"/issuer/0001863127","role":"Other","n_filings":1,"first_seen":"2021-09-21","last_seen":"2021-09-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001798749","name":"Aerovate Therapeutics, Inc.","url":"/issuer/0001798749","role":"Other","n_filings":1,"first_seen":"2021-07-07","last_seen":"2021-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001783032","name":"Elevation Oncology, Inc.","url":"/issuer/0001783032","role":"Other","n_filings":1,"first_seen":"2021-07-01","last_seen":"2021-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001826457","name":"Monte Rosa Therapeutics, Inc.","url":"/issuer/0001826457","role":"Other","n_filings":1,"first_seen":"2021-06-30","last_seen":"2021-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001840574","name":"Verve Therapeutics, Inc.","url":"/issuer/0001840574","role":"Other","n_filings":1,"first_seen":"2021-06-23","last_seen":"2021-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001724979","name":"Rain Therapeutics Inc.","url":"/issuer/0001724979","role":"Other","n_filings":1,"first_seen":"2021-04-29","last_seen":"2021-04-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001807120","name":"Design Therapeutics, Inc.","url":"/issuer/0001807120","role":"Other","n_filings":1,"first_seen":"2021-04-01","last_seen":"2021-04-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001718852","name":"Prometheus Biosciences, Inc.","url":"/issuer/0001718852","role":"Other","n_filings":1,"first_seen":"2021-03-18","last_seen":"2021-03-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001826892","name":"BioAtla, Inc.","url":"/issuer/0001826892","role":"Other","n_filings":1,"first_seen":"2020-12-22","last_seen":"2020-12-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001750284","name":"Olema Pharmaceuticals, Inc.","url":"/issuer/0001750284","role":"Other","n_filings":1,"first_seen":"2020-11-23","last_seen":"2020-11-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001722271","name":"Akouos, Inc.","url":"/issuer/0001722271","role":"Other","n_filings":1,"first_seen":"2020-07-02","last_seen":"2020-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001599901","name":"Avidity Biosciences, Inc.","url":"/issuer/0001599901","role":"Other","n_filings":1,"first_seen":"2020-06-18","last_seen":"2020-06-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001595893","name":"Turning Point Therapeutics, Inc.","url":"/issuer/0001595893","role":"Ten percent owner","n_filings":1,"first_seen":"2019-04-25","last_seen":"2019-04-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001603756","name":"Axonics Modulation Technologies, Inc.","url":"/issuer/0001603756","role":"Ten percent owner","n_filings":1,"first_seen":"2018-11-02","last_seen":"2018-11-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001645666","name":"Kezar Life Sciences, Inc.","url":"/issuer/0001645666","role":"Ten percent owner","n_filings":1,"first_seen":"2018-06-27","last_seen":"2018-06-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals, Ltd.","url":"/issuer/0001730430","role":"Ten percent owner","n_filings":1,"first_seen":"2018-05-31","last_seen":"2018-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001445283","name":"PROTEOSTASIS THERAPEUTICS, INC.","url":"/issuer/0001445283","role":"Ten percent owner","n_filings":8,"first_seen":"2016-11-07","last_seen":"2017-12-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Ten percent owner","n_filings":1,"first_seen":"2017-11-14","last_seen":"2017-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001583977","retrieved_at":"2026-08-23T16:11:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}